Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer

NCT03012100 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

280

Enrollment

OTHER

Sponsor class

Conditions

Bilateral Breast Carcinoma
Breast Inflammatory Carcinoma
Stage IB Breast Cancer AJCC v7
Stage II Breast Cancer AJCC v6 and v7
Stage IIA Breast Cancer AJCC v6 and v7
Stage IIB Breast Cancer AJCC v6 and v7
Stage III Breast Cancer AJCC v7
Stage IIIA Breast Cancer AJCC v7
Stage IIIB Breast Cancer AJCC v7
Stage IIIC Breast Cancer AJCC v7
Triple-Negative Breast Carcinoma
Unilateral Breast Carcinoma

Interventions

DRUG: Cyclophosphamide
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Multi-epitope Folate Receptor Alpha Peptide Vaccine
OTHER: Placebo Administration
BIOLOGICAL: Sargramostim

Sponsor

Academic and Community Cancer Research United

Collaborators

[object Object]